renca Search Results


renca  (ATCC)
96
ATCC renca
Renca, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/renca/product/ATCC
Average 96 stars, based on 1 article reviews
renca - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
ATCC renal cortical adenocarcinoma
Renal Cortical Adenocarcinoma, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/renal cortical adenocarcinoma/product/ATCC
Average 95 stars, based on 1 article reviews
renal cortical adenocarcinoma - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
CLS Cell Lines Service GmbH renca cells
Renca Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/renca cells/product/CLS Cell Lines Service GmbH
Average 90 stars, based on 1 article reviews
renca cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AMS Biotechnology renca cells
Bioluminescent imaging (BLI) of orthotopically implanted <t>Renca</t> cells and spontaneous lung metastases. (A) Representative bioluminescent images of BALB/c mice following intrarenal injection of 1×10 <t>5</t> <t>Renca/luc</t> or Renca(HM)/luc cells. (B) Higher BLI signal intensity (higher tumor burden) on day 5 following Renca(HM)/luc cell implantation (relative to day 9 following Renca/luc cell implantation) ( n =2 for each day 5, 9, 14, 19, and 23 post implantation, total n =10 for Renca/luc and Renca(HM)/luc, respectively).
Renca Cells, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/renca cells/product/AMS Biotechnology
Average 90 stars, based on 1 article reviews
renca cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Procell Inc murine renal cancer cell lines renca
Bioluminescent imaging (BLI) of orthotopically implanted <t>Renca</t> cells and spontaneous lung metastases. (A) Representative bioluminescent images of BALB/c mice following intrarenal injection of 1×10 <t>5</t> <t>Renca/luc</t> or Renca(HM)/luc cells. (B) Higher BLI signal intensity (higher tumor burden) on day 5 following Renca(HM)/luc cell implantation (relative to day 9 following Renca/luc cell implantation) ( n =2 for each day 5, 9, 14, 19, and 23 post implantation, total n =10 for Renca/luc and Renca(HM)/luc, respectively).
Murine Renal Cancer Cell Lines Renca, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/murine renal cancer cell lines renca/product/Procell Inc
Average 90 stars, based on 1 article reviews
murine renal cancer cell lines renca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Jackson Laboratory luciferase-transfected renca cells
Bioluminescent imaging (BLI) of orthotopically implanted <t>Renca</t> cells and spontaneous lung metastases. (A) Representative bioluminescent images of BALB/c mice following intrarenal injection of 1×10 <t>5</t> <t>Renca/luc</t> or Renca(HM)/luc cells. (B) Higher BLI signal intensity (higher tumor burden) on day 5 following Renca(HM)/luc cell implantation (relative to day 9 following Renca/luc cell implantation) ( n =2 for each day 5, 9, 14, 19, and 23 post implantation, total n =10 for Renca/luc and Renca(HM)/luc, respectively).
Luciferase Transfected Renca Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luciferase-transfected renca cells/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
luciferase-transfected renca cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Korean Cell Line Bank renca cells
Combined therapy with ISTF and anti-4-1BB mAb has antitumor effects in mice inoculated with <t>Renca</t> <t>cells.</t> Mice were inoculated with Renca tumor cells on day 0. Tumor-bearing mice were divided into four groups and treated with the following reagents: i) PBS and control mAb (rat IgG); ii) ISTF monotherapy; iii) 4-1BB mAb monotherapy; and iv) ISTF and 4-1BB mAb combined. Mice were subcutaneously injected with Renca tumor cells (1×10 6 /mouse). ISTF (100 µg/mouse) was injected i.p. on days 3, 7 and 12, and anti-4-1BB mAb (100 µg/mouse) was injected i.p. on days 7 and 12, while a control group received PBS and/or rat IgG, respectively. Tumor diameter was measured every 2–3 days, and tumor volume (in mm 3 ) was calculated using a caliper. Tumor size was expressed as tumor volume based on the following formula: Tumor volume (mm 3 )=(major axis) × (minor axis) × (height) ×0.52. (A) Effect of combined therapy with ISTF and anti-4-1BB mAb on Renca tumor volume. Each line indicates the tumor volume of the individual animal. Results shown are representative of three independent experiments. n, number of mice per experiment. (B) Representative images of tumors on days 21 in the same condition as (A). (C) Serum ALT and AST were measured. (D) Survival rate of mice was determined. The animals were sacrificed when the longest dimensions of the tumors were >20 mm. Comparison of survival curves with log-rank test yielded a statistical significance of ***P<0.001. NS, not significant; ISTF, immunostimulatory factor; mAb, monoclonal antibody; i.p., intraperitoneally; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Renca Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/renca cells/product/Korean Cell Line Bank
Average 90 stars, based on 1 article reviews
renca cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Centocor Inc renca cells
Combined therapy with ISTF and anti-4-1BB mAb has antitumor effects in mice inoculated with <t>Renca</t> <t>cells.</t> Mice were inoculated with Renca tumor cells on day 0. Tumor-bearing mice were divided into four groups and treated with the following reagents: i) PBS and control mAb (rat IgG); ii) ISTF monotherapy; iii) 4-1BB mAb monotherapy; and iv) ISTF and 4-1BB mAb combined. Mice were subcutaneously injected with Renca tumor cells (1×10 6 /mouse). ISTF (100 µg/mouse) was injected i.p. on days 3, 7 and 12, and anti-4-1BB mAb (100 µg/mouse) was injected i.p. on days 7 and 12, while a control group received PBS and/or rat IgG, respectively. Tumor diameter was measured every 2–3 days, and tumor volume (in mm 3 ) was calculated using a caliper. Tumor size was expressed as tumor volume based on the following formula: Tumor volume (mm 3 )=(major axis) × (minor axis) × (height) ×0.52. (A) Effect of combined therapy with ISTF and anti-4-1BB mAb on Renca tumor volume. Each line indicates the tumor volume of the individual animal. Results shown are representative of three independent experiments. n, number of mice per experiment. (B) Representative images of tumors on days 21 in the same condition as (A). (C) Serum ALT and AST were measured. (D) Survival rate of mice was determined. The animals were sacrificed when the longest dimensions of the tumors were >20 mm. Comparison of survival curves with log-rank test yielded a statistical significance of ***P<0.001. NS, not significant; ISTF, immunostimulatory factor; mAb, monoclonal antibody; i.p., intraperitoneally; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Renca Cells, supplied by Centocor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/renca cells/product/Centocor Inc
Average 90 stars, based on 1 article reviews
renca cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Procell Inc renca
Combined therapy with ISTF and anti-4-1BB mAb has antitumor effects in mice inoculated with <t>Renca</t> <t>cells.</t> Mice were inoculated with Renca tumor cells on day 0. Tumor-bearing mice were divided into four groups and treated with the following reagents: i) PBS and control mAb (rat IgG); ii) ISTF monotherapy; iii) 4-1BB mAb monotherapy; and iv) ISTF and 4-1BB mAb combined. Mice were subcutaneously injected with Renca tumor cells (1×10 6 /mouse). ISTF (100 µg/mouse) was injected i.p. on days 3, 7 and 12, and anti-4-1BB mAb (100 µg/mouse) was injected i.p. on days 7 and 12, while a control group received PBS and/or rat IgG, respectively. Tumor diameter was measured every 2–3 days, and tumor volume (in mm 3 ) was calculated using a caliper. Tumor size was expressed as tumor volume based on the following formula: Tumor volume (mm 3 )=(major axis) × (minor axis) × (height) ×0.52. (A) Effect of combined therapy with ISTF and anti-4-1BB mAb on Renca tumor volume. Each line indicates the tumor volume of the individual animal. Results shown are representative of three independent experiments. n, number of mice per experiment. (B) Representative images of tumors on days 21 in the same condition as (A). (C) Serum ALT and AST were measured. (D) Survival rate of mice was determined. The animals were sacrificed when the longest dimensions of the tumors were >20 mm. Comparison of survival curves with log-rank test yielded a statistical significance of ***P<0.001. NS, not significant; ISTF, immunostimulatory factor; mAb, monoclonal antibody; i.p., intraperitoneally; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Renca, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/renca/product/Procell Inc
Average 90 stars, based on 1 article reviews
renca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Procell Inc kidney cancer renca
Combined therapy with ISTF and anti-4-1BB mAb has antitumor effects in mice inoculated with <t>Renca</t> <t>cells.</t> Mice were inoculated with Renca tumor cells on day 0. Tumor-bearing mice were divided into four groups and treated with the following reagents: i) PBS and control mAb (rat IgG); ii) ISTF monotherapy; iii) 4-1BB mAb monotherapy; and iv) ISTF and 4-1BB mAb combined. Mice were subcutaneously injected with Renca tumor cells (1×10 6 /mouse). ISTF (100 µg/mouse) was injected i.p. on days 3, 7 and 12, and anti-4-1BB mAb (100 µg/mouse) was injected i.p. on days 7 and 12, while a control group received PBS and/or rat IgG, respectively. Tumor diameter was measured every 2–3 days, and tumor volume (in mm 3 ) was calculated using a caliper. Tumor size was expressed as tumor volume based on the following formula: Tumor volume (mm 3 )=(major axis) × (minor axis) × (height) ×0.52. (A) Effect of combined therapy with ISTF and anti-4-1BB mAb on Renca tumor volume. Each line indicates the tumor volume of the individual animal. Results shown are representative of three independent experiments. n, number of mice per experiment. (B) Representative images of tumors on days 21 in the same condition as (A). (C) Serum ALT and AST were measured. (D) Survival rate of mice was determined. The animals were sacrificed when the longest dimensions of the tumors were >20 mm. Comparison of survival curves with log-rank test yielded a statistical significance of ***P<0.001. NS, not significant; ISTF, immunostimulatory factor; mAb, monoclonal antibody; i.p., intraperitoneally; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Kidney Cancer Renca, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kidney cancer renca/product/Procell Inc
Average 90 stars, based on 1 article reviews
kidney cancer renca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Aurigene Inc renca (mouse renal carcinoma; crl-2947) cells
Combined therapy with ISTF and anti-4-1BB mAb has antitumor effects in mice inoculated with <t>Renca</t> <t>cells.</t> Mice were inoculated with Renca tumor cells on day 0. Tumor-bearing mice were divided into four groups and treated with the following reagents: i) PBS and control mAb (rat IgG); ii) ISTF monotherapy; iii) 4-1BB mAb monotherapy; and iv) ISTF and 4-1BB mAb combined. Mice were subcutaneously injected with Renca tumor cells (1×10 6 /mouse). ISTF (100 µg/mouse) was injected i.p. on days 3, 7 and 12, and anti-4-1BB mAb (100 µg/mouse) was injected i.p. on days 7 and 12, while a control group received PBS and/or rat IgG, respectively. Tumor diameter was measured every 2–3 days, and tumor volume (in mm 3 ) was calculated using a caliper. Tumor size was expressed as tumor volume based on the following formula: Tumor volume (mm 3 )=(major axis) × (minor axis) × (height) ×0.52. (A) Effect of combined therapy with ISTF and anti-4-1BB mAb on Renca tumor volume. Each line indicates the tumor volume of the individual animal. Results shown are representative of three independent experiments. n, number of mice per experiment. (B) Representative images of tumors on days 21 in the same condition as (A). (C) Serum ALT and AST were measured. (D) Survival rate of mice was determined. The animals were sacrificed when the longest dimensions of the tumors were >20 mm. Comparison of survival curves with log-rank test yielded a statistical significance of ***P<0.001. NS, not significant; ISTF, immunostimulatory factor; mAb, monoclonal antibody; i.p., intraperitoneally; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Renca (Mouse Renal Carcinoma; Crl 2947) Cells, supplied by Aurigene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/renca (mouse renal carcinoma; crl-2947) cells/product/Aurigene Inc
Average 90 stars, based on 1 article reviews
renca (mouse renal carcinoma; crl-2947) cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Onyvax Ltd renca, murine renal cancer, cells
Combined therapy with ISTF and anti-4-1BB mAb has antitumor effects in mice inoculated with <t>Renca</t> <t>cells.</t> Mice were inoculated with Renca tumor cells on day 0. Tumor-bearing mice were divided into four groups and treated with the following reagents: i) PBS and control mAb (rat IgG); ii) ISTF monotherapy; iii) 4-1BB mAb monotherapy; and iv) ISTF and 4-1BB mAb combined. Mice were subcutaneously injected with Renca tumor cells (1×10 6 /mouse). ISTF (100 µg/mouse) was injected i.p. on days 3, 7 and 12, and anti-4-1BB mAb (100 µg/mouse) was injected i.p. on days 7 and 12, while a control group received PBS and/or rat IgG, respectively. Tumor diameter was measured every 2–3 days, and tumor volume (in mm 3 ) was calculated using a caliper. Tumor size was expressed as tumor volume based on the following formula: Tumor volume (mm 3 )=(major axis) × (minor axis) × (height) ×0.52. (A) Effect of combined therapy with ISTF and anti-4-1BB mAb on Renca tumor volume. Each line indicates the tumor volume of the individual animal. Results shown are representative of three independent experiments. n, number of mice per experiment. (B) Representative images of tumors on days 21 in the same condition as (A). (C) Serum ALT and AST were measured. (D) Survival rate of mice was determined. The animals were sacrificed when the longest dimensions of the tumors were >20 mm. Comparison of survival curves with log-rank test yielded a statistical significance of ***P<0.001. NS, not significant; ISTF, immunostimulatory factor; mAb, monoclonal antibody; i.p., intraperitoneally; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Renca, Murine Renal Cancer, Cells, supplied by Onyvax Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/renca, murine renal cancer, cells/product/Onyvax Ltd
Average 90 stars, based on 1 article reviews
renca, murine renal cancer, cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Bioluminescent imaging (BLI) of orthotopically implanted Renca cells and spontaneous lung metastases. (A) Representative bioluminescent images of BALB/c mice following intrarenal injection of 1×10 5 Renca/luc or Renca(HM)/luc cells. (B) Higher BLI signal intensity (higher tumor burden) on day 5 following Renca(HM)/luc cell implantation (relative to day 9 following Renca/luc cell implantation) ( n =2 for each day 5, 9, 14, 19, and 23 post implantation, total n =10 for Renca/luc and Renca(HM)/luc, respectively).

Journal: Biology Open

Article Title: Development of a highly pulmonary metastatic orthotopic renal cell carcinoma murine model

doi: 10.1242/bio.058566

Figure Lengend Snippet: Bioluminescent imaging (BLI) of orthotopically implanted Renca cells and spontaneous lung metastases. (A) Representative bioluminescent images of BALB/c mice following intrarenal injection of 1×10 5 Renca/luc or Renca(HM)/luc cells. (B) Higher BLI signal intensity (higher tumor burden) on day 5 following Renca(HM)/luc cell implantation (relative to day 9 following Renca/luc cell implantation) ( n =2 for each day 5, 9, 14, 19, and 23 post implantation, total n =10 for Renca/luc and Renca(HM)/luc, respectively).

Article Snippet: To induce stable expression of red fluorescent protein (RFP) and firefly luciferase (luc), Renca cells were transfected using a commercially available lentiviral vector containing luc 3 and RFP genes under control of an inducible suCMV promoter (Amsbio, Cambridge, MA, USA).

Techniques: Imaging, Injection

Schematic representation of the in vivo selection process. Cell lines were intrarenally injected (orthotopic implantation) in mouse (A), followed by isolation of tumor cells from pulmonary metastases for expansion culture and reinjection in another mouse (B). (1) Initial Renca/luc cell implantation. (2) Isolation of metastatic tumor cells from pulmonary lesions. (3) In vivo selection of the highly pulmonary metastatic cell subpopulation, termed Renca(HM)/luc. (4) Final reimplantation of Renca(HM)/luc cells.

Journal: Biology Open

Article Title: Development of a highly pulmonary metastatic orthotopic renal cell carcinoma murine model

doi: 10.1242/bio.058566

Figure Lengend Snippet: Schematic representation of the in vivo selection process. Cell lines were intrarenally injected (orthotopic implantation) in mouse (A), followed by isolation of tumor cells from pulmonary metastases for expansion culture and reinjection in another mouse (B). (1) Initial Renca/luc cell implantation. (2) Isolation of metastatic tumor cells from pulmonary lesions. (3) In vivo selection of the highly pulmonary metastatic cell subpopulation, termed Renca(HM)/luc. (4) Final reimplantation of Renca(HM)/luc cells.

Article Snippet: To induce stable expression of red fluorescent protein (RFP) and firefly luciferase (luc), Renca cells were transfected using a commercially available lentiviral vector containing luc 3 and RFP genes under control of an inducible suCMV promoter (Amsbio, Cambridge, MA, USA).

Techniques: In Vivo, Selection, Injection, Isolation

Progression rate of primary renal tumors and lung metastatic lesions. (A) Kaplan–Meier survival curves, indicating significantly shorter survival intervals for Renca(HM)/luc cell-implanted mice than for Renca/luc cell-implanted mice ( n =10 for Renca/luc and Renca(HM)/luc). The dotted line represents the Kaplan–Meier survival curve following final Renca(HM)/luc cell-reimplantation(2nd study, n =10). (B) Excised tumor-bearing kidney weights of Renca/luc cell-implanted mice relative to those of Renca(HM)/luc cell-implanted mice ( n =10 for Renca/luc tumor-bearing, and Renca(HM)/luc tumor bearing kidneys). (C) Higher weight of the tumor-bearing kidney (more rapid tumor growth) following Renca(HM)/luc cell implantation (relative to Renca/luc cell implantation) ( n =2 for each day 5, 9, 14, 19, and 23 post-implantation, total n =10 for Renca/luc and Renca(HM)/luc, respectively).

Journal: Biology Open

Article Title: Development of a highly pulmonary metastatic orthotopic renal cell carcinoma murine model

doi: 10.1242/bio.058566

Figure Lengend Snippet: Progression rate of primary renal tumors and lung metastatic lesions. (A) Kaplan–Meier survival curves, indicating significantly shorter survival intervals for Renca(HM)/luc cell-implanted mice than for Renca/luc cell-implanted mice ( n =10 for Renca/luc and Renca(HM)/luc). The dotted line represents the Kaplan–Meier survival curve following final Renca(HM)/luc cell-reimplantation(2nd study, n =10). (B) Excised tumor-bearing kidney weights of Renca/luc cell-implanted mice relative to those of Renca(HM)/luc cell-implanted mice ( n =10 for Renca/luc tumor-bearing, and Renca(HM)/luc tumor bearing kidneys). (C) Higher weight of the tumor-bearing kidney (more rapid tumor growth) following Renca(HM)/luc cell implantation (relative to Renca/luc cell implantation) ( n =2 for each day 5, 9, 14, 19, and 23 post-implantation, total n =10 for Renca/luc and Renca(HM)/luc, respectively).

Article Snippet: To induce stable expression of red fluorescent protein (RFP) and firefly luciferase (luc), Renca cells were transfected using a commercially available lentiviral vector containing luc 3 and RFP genes under control of an inducible suCMV promoter (Amsbio, Cambridge, MA, USA).

Techniques:

Spontaneous lung metastasis following intrarenal implantation of highly pulmonary metastatic Renca(HM)/luc cells. (A) Bioluminescent imaging demonstrating early (day 5) lung metastatic lesions in Renca(HM)/luc cell-implanted mice versus no signal in Renca/luc cell-implanted mice. (B) Number of pulmonary metastatic lesions over time, demonstrating more lesions in Renca(HM)/luc cell-implanted mice than in Renca/luc cell-implanted mice. (C) Pulmonary metastatic lesions visualized via India ink-insufflation in Renca/luc cell-implanted mice and Renca(HM)/luc cell-implanted mice on day 23 post-implantation. Scale bars: 5 mm. (D) Number of pulmonary metastases over time, demonstrating significantly more lesions in Renca(HM)/luc cell-implanted mice than in Renca/luc cell-implanted mice [ n =2 for each day 5, 9, 14, 19, and 23 post-implantation, total n =10 for Renca/luc and Renca(HM)/luc, respectively].

Journal: Biology Open

Article Title: Development of a highly pulmonary metastatic orthotopic renal cell carcinoma murine model

doi: 10.1242/bio.058566

Figure Lengend Snippet: Spontaneous lung metastasis following intrarenal implantation of highly pulmonary metastatic Renca(HM)/luc cells. (A) Bioluminescent imaging demonstrating early (day 5) lung metastatic lesions in Renca(HM)/luc cell-implanted mice versus no signal in Renca/luc cell-implanted mice. (B) Number of pulmonary metastatic lesions over time, demonstrating more lesions in Renca(HM)/luc cell-implanted mice than in Renca/luc cell-implanted mice. (C) Pulmonary metastatic lesions visualized via India ink-insufflation in Renca/luc cell-implanted mice and Renca(HM)/luc cell-implanted mice on day 23 post-implantation. Scale bars: 5 mm. (D) Number of pulmonary metastases over time, demonstrating significantly more lesions in Renca(HM)/luc cell-implanted mice than in Renca/luc cell-implanted mice [ n =2 for each day 5, 9, 14, 19, and 23 post-implantation, total n =10 for Renca/luc and Renca(HM)/luc, respectively].

Article Snippet: To induce stable expression of red fluorescent protein (RFP) and firefly luciferase (luc), Renca cells were transfected using a commercially available lentiviral vector containing luc 3 and RFP genes under control of an inducible suCMV promoter (Amsbio, Cambridge, MA, USA).

Techniques: Imaging

Combined therapy with ISTF and anti-4-1BB mAb has antitumor effects in mice inoculated with Renca cells. Mice were inoculated with Renca tumor cells on day 0. Tumor-bearing mice were divided into four groups and treated with the following reagents: i) PBS and control mAb (rat IgG); ii) ISTF monotherapy; iii) 4-1BB mAb monotherapy; and iv) ISTF and 4-1BB mAb combined. Mice were subcutaneously injected with Renca tumor cells (1×10 6 /mouse). ISTF (100 µg/mouse) was injected i.p. on days 3, 7 and 12, and anti-4-1BB mAb (100 µg/mouse) was injected i.p. on days 7 and 12, while a control group received PBS and/or rat IgG, respectively. Tumor diameter was measured every 2–3 days, and tumor volume (in mm 3 ) was calculated using a caliper. Tumor size was expressed as tumor volume based on the following formula: Tumor volume (mm 3 )=(major axis) × (minor axis) × (height) ×0.52. (A) Effect of combined therapy with ISTF and anti-4-1BB mAb on Renca tumor volume. Each line indicates the tumor volume of the individual animal. Results shown are representative of three independent experiments. n, number of mice per experiment. (B) Representative images of tumors on days 21 in the same condition as (A). (C) Serum ALT and AST were measured. (D) Survival rate of mice was determined. The animals were sacrificed when the longest dimensions of the tumors were >20 mm. Comparison of survival curves with log-rank test yielded a statistical significance of ***P<0.001. NS, not significant; ISTF, immunostimulatory factor; mAb, monoclonal antibody; i.p., intraperitoneally; ALT, alanine aminotransferase; AST, aspartate aminotransferase.

Journal: Oncology Letters

Article Title: Anti-4-1BB antibody-based combination therapy augments antitumor immunity by enhancing CD11c + CD8 + T cells in renal cell carcinoma

doi: 10.3892/ol.2021.13161

Figure Lengend Snippet: Combined therapy with ISTF and anti-4-1BB mAb has antitumor effects in mice inoculated with Renca cells. Mice were inoculated with Renca tumor cells on day 0. Tumor-bearing mice were divided into four groups and treated with the following reagents: i) PBS and control mAb (rat IgG); ii) ISTF monotherapy; iii) 4-1BB mAb monotherapy; and iv) ISTF and 4-1BB mAb combined. Mice were subcutaneously injected with Renca tumor cells (1×10 6 /mouse). ISTF (100 µg/mouse) was injected i.p. on days 3, 7 and 12, and anti-4-1BB mAb (100 µg/mouse) was injected i.p. on days 7 and 12, while a control group received PBS and/or rat IgG, respectively. Tumor diameter was measured every 2–3 days, and tumor volume (in mm 3 ) was calculated using a caliper. Tumor size was expressed as tumor volume based on the following formula: Tumor volume (mm 3 )=(major axis) × (minor axis) × (height) ×0.52. (A) Effect of combined therapy with ISTF and anti-4-1BB mAb on Renca tumor volume. Each line indicates the tumor volume of the individual animal. Results shown are representative of three independent experiments. n, number of mice per experiment. (B) Representative images of tumors on days 21 in the same condition as (A). (C) Serum ALT and AST were measured. (D) Survival rate of mice was determined. The animals were sacrificed when the longest dimensions of the tumors were >20 mm. Comparison of survival curves with log-rank test yielded a statistical significance of ***P<0.001. NS, not significant; ISTF, immunostimulatory factor; mAb, monoclonal antibody; i.p., intraperitoneally; ALT, alanine aminotransferase; AST, aspartate aminotransferase.

Article Snippet: Renca cells were purchased from the Korean Cell Line Bank (Korean Cell Line Research Foundation) and cultured in RPMI-1640 medium (Gibco; Thermo Fisher Scientific, Inc.) supplemented with 10% FBS (Gibco; Thermo Fisher Scientific, Inc.).

Techniques: Control, Injection, Comparison